Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IniXium
Laval, Quebec, Canada
- Ownership
- Private
- Employees
- ~5
- Development stage
- Other
01
Overview
IniXium is a contract research organization providing pre-clinical research services in recombinant protein production, biophysical characterization, protein crystallography, fragment screening, and biologics/biosimilars to support small-molecule and biologic drug discovery for biotech and pharmaceutical clients.[1][3][4][5]
- Modalities
- BiologicProteinMonoclonal antibodyBiologics and biosimilars
- Industry
- Drug Discovery Services
02
Partnerships
NuChem Sciences (acquirer and integrated structural biology/drug discovery partner)[1][3]
Beyond the preview
Go deeper on IniXium.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IniXium.